Markets:

Overview

News

Currencies

International

Treasuries

Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)

28.22 -1.90 (-6.31%)

Streaming Delayed Price Updated: 1:25 PM EDT, May 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mineralys Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps ↗

June 17, 2025

Mineralys reports Phase 2 trial success for lorundrostat, showing BP and kidney improvements in CKD patients with favorable safety results.

Via Benzinga

This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

June 11, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Uncovering Potential: Mineralys Therapeutics's Earnings Preview ↗

May 09, 2025

Via Benzinga

Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1 ↗

April 01, 2025

Three small-cap stocks have intrigued Stocktwits users the most among the biotech sector this year, thanks to promising data from clinical trials and a leadership shuffle.

Via Stocktwits

Earnings Scheduled For February 12, 2025 ↗

February 12, 2025

Via Benzinga

Insights into Mineralys Therapeutics's Upcoming Earnings ↗

November 08, 2024

Via Benzinga

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week ↗

March 16, 2025

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

Via Stocktwits

Unusual volume stocks are being observed in Wednesday's session. ↗

March 12, 2025

Which stocks have an unusual volume on Wednesday?

Via Chartmill

Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 12, 2025

Via Benzinga

Keep an eye on the top gainers and losers in Monday's session. ↗

March 10, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Monday's session: top gainers and losers ↗

March 10, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate ↗

March 10, 2025

Mineralys Therapeutics' lorundrostat met key Phase 3 and Phase 2 trial endpoints for hypertension, showing significant blood pressure reductions and a strong safety profile.

Via Benzinga

Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher ↗

March 10, 2025

Via Benzinga

Topics Stocks

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 10, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday ↗

March 10, 2025

Via Benzinga

Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket ↗

March 10, 2025

Via Benzinga

Which stocks are moving after the closing bell on Friday? ↗

March 07, 2025

The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

February 06, 2025

Via Benzinga

Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

January 29, 2025

Via Benzinga

Ericsson Posts Weak Results, Joins East West Bancorp And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

January 24, 2025

Via Benzinga

Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗

January 24, 2025

Via Benzinga

Earnings Scheduled For November 11, 2024 ↗

November 11, 2024

Via Benzinga

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

September 20, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

September 12, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

September 09, 2024

From Schall Law

Via GlobeNewswire

MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q2 2024 ↗

August 13, 2024

MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024 ↗

May 09, 2024

MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

MLYS Stock Earnings: Mineralys Therapeutics Beats EPS for Q4 2023 ↗

March 21, 2024

MLYS stock results show that Mineralys Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For March 21, 2024 ↗

March 21, 2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.